TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT02537821 — Safety Biomarker (SAF): Human leucocyte antigen
Study NCT02537821 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT00513604 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT03231501 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03231501 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04269304 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT00765674 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00950950 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00360438 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT02516475 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02516475 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02757391 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT01121068 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT01403896 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01403896 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT00007592 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01957449 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03635073 — Predictive Biomarker (PRD): Cyclin-dependent kinase-like 5
Genes: CDKL5; STK9
Study NCT02303327 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT01956292 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03952325 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03952325 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT03952325 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT03952325 — Predictive Biomarker (PRD): Hormone receptor
Study NCT03444350 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT00786383 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02136979 — Predictive Biomarker (PRD): ENTPD1 mRNA
Genes: ENTPD1; CD39
Study NCT01735851 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02154204 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04377750 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT03982381 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT00186966 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00379847 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study NCT00379847 — Surrogate Endpoint (SUR): Serum sodium
Study NCT00474695 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00474695 — Predictive Biomarker (PRD): HTRA1 mRNA
Genes: HTRA1; HTRA; PRSS11
Study NCT03693703 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study NCT02542774 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04513015 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT04513015 — Predictive Biomarker (PRD); Safety Biomarker (SAF): SOD2 mRNA
Genes: SOD2
Study NCT04513015 — Predictive Biomarker (PRD): SOD3 mRNA
Genes: SOD3
Study NCT04513015 — Predictive Biomarker (PRD): GPX1 mRNA
Genes: GPX1
Study NCT04513015 — Predictive Biomarker (PRD): GPX2 mRNA
Genes: GPX2
Study NCT04513015 — Predictive Biomarker (PRD): GPX3 mRNA
Genes: GPX3; GPXP
Study NCT04513015 — Predictive Biomarker (PRD): GPX4 mRNA
Genes: GPX4
Study NCT04513015 — Predictive Biomarker (PRD): GSTA2 mRNA
Genes: GSTA2; GST2
Study NCT04513015 — Predictive Biomarker (PRD): GSTM1 mRNA
Genes: GSTM1; GST1
Study NCT04513015 — Predictive Biomarker (PRD): GSTM2 mRNA
Genes: GSTM2; GST4
Study NCT04513015 — Predictive Biomarker (PRD): GSTM3 mRNA
Genes: GSTM3; GST5
Study NCT04513015 — Safety Biomarker (SAF): Glutathione S-transferase P
Genes: GSTP1; FAEES3; GST3
Study NCT04513015 — Predictive Biomarker (PRD): NOX1 mRNA
Genes: NOX1; MOX1; NOH1
Study NCT04513015 — Predictive Biomarker (PRD): NOX4 mRNA
Genes: NOX4; RENOX
Study NCT04513015 — Predictive Biomarker (PRD): NOX5 mRNA
Genes: NOX5
Study NCT01842490 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT00596193 — Predictive Biomarker (PRD): NPY mRNA
Genes: NPY
Study NCT04428398 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02149251 — Predictive Biomarker (PRD): PGD mRNA
Genes: PGD; PGDH
Study NCT03234205 — Predictive Biomarker (PRD): DCLRE1C mRNA
Genes: DCLRE1C; ARTEMIS; ASCID; SCIDA; SNM1C
Study NCT02533414 — Safety Biomarker (SAF): Netrin-1
Genes: NTN1; NTN1L
Study NCT04047706 — Predictive Biomarker (PRD): Indoleamine 2,3-dioxygenase 1
Genes: IDO1; IDO; INDO
Study NCT04630132 — Predictive Biomarker (PRD): KL mRNA
Genes: KL
Study NCT04578197 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02560311 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00952302 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01310088 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01331603 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT04472611 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01710839 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03541174 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02349633 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02349633 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00303823 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT01655589 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00637078 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT02139293 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03122041 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT03566446 — Predictive Biomarker (PRD): CALR mRNA
Genes: CALR; CRTC
Study NCT02000895 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT02000895 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT02609308 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03843749 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03663829 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01259206 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study NCT00798915 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT03268382 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT03268382 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT04447664 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT00633724 — Predictive Biomarker (PRD): TTK mRNA
Genes: TTK; MPS1; MPS1L1
Study NCT00633724 — Predictive Biomarker (PRD): FLT1 mRNA
Genes: FLT1; FLT; FRT; VEGFR1
Study NCT00633724 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study NCT00633724 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT04178044 — Pharmacodynamic Biomarker (PDY): Antidrug antibody
Study NCT00252421 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04113122 — Predictive Biomarker (PRD): ASPRV1 mRNA
Genes: ASPRV1; SASP
Study NCT02399215 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03176836 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT00717665 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00001832 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00001832 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT00001832 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT01169662 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03483961 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT03707353 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): TNF related activation protein
Genes: CD40LG; CD40L; TNFSF5; TRAP
Study NCT03209622 — Surrogate Endpoint (SUR): Exhaled carbon monoxide
Study NCT02291497 — Predictive Biomarker (PRD): ALPL mRNA
Genes: ALPL
Study NCT02367820 — Predictive Biomarker (PRD): NKTR mRNA
Genes: NKTR
Study NCT00333775 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02110563 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study NCT00710853 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01376427 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT01376427 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT03211754 — Surrogate Endpoint (SUR): Serum LDL cholesterol
Study NCT01274026 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT02630693 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02630693 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT05314790 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT01907373 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT04849494 — Predictive Biomarker (PRD): AGA mRNA
Genes: AGA
Study NCT03093896 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT03093896 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03093896 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT01216202 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT00982735 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01163370 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02882139 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT00636077 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P
Study NCT03785171 — Predictive Biomarker (PRD): MMD mRNA
Genes: MMD; PAQR11
Study NCT04739072 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT00428090 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT04489862 — Predictive Biomarker (PRD): MSLN mRNA
Genes: MSLN; MPF
Study NCT03855696 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT00653445 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01944371 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01145742 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03972657 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT02559622 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03678207 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01984866 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT01004822 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01004822 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Angiopoietin-2
Genes: ANGPT2
Study NCT01004822 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00354991 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00509275 — Predictive Biomarker (PRD): MTTP mRNA
Genes: MTTP; MTP
Study NCT00001522 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00993941 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT01723735 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT01723735 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01464086 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT01020110 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT04602481 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01112137 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study NCT01112137 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04553185 — Predictive Biomarker (PRD): AQP4 mRNA
Genes: AQP4
Study NCT01913938 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01130961 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03960788 — Predictive Biomarker (PRD): SLCO1B3 mRNA
Genes: SLCO1B3; LST2; OATP1B3; OATP8; SLC21A8
Study NCT04231903 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study NCT00272389 — Predictive Biomarker (PRD): OAS3 mRNA
Genes: OAS3; P/OKcl.4
Study NCT00272389 — Predictive Biomarker (PRD): OAS2 mRNA
Genes: OAS2
Study NCT03332368 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT03332368 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00384072 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03814499 — Predictive Biomarker (PRD): MYO7A mRNA
Genes: MYO7A; USH1B
Study NCT01714726 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03122600 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT01293487 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02996565 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04673253 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01848392 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00912548 — Predictive Biomarker (PRD): Hormone receptor
Study NCT00698646 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04854343 — Predictive Biomarker (PRD): SLPI mRNA
Genes: SLPI; WAP4; WFDC4
Study NCT03515577 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT00637429 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00637429 — Monitoring Biomarker (MOI): HBV DNA
Study NCT00574613 — Safety Biomarker (SAF): Transforming growth factor beta 1
Genes: TGFB1; TGFB
Study NCT00819390 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00819390 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT03780075 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT01890876 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT00000140 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study NCT03770910 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT00025597 — Predictive Biomarker (PRD): MYCN mRNA
Genes: MYCN; BHLHE37; NMYC
Study NCT03790111 — Predictive Biomarker (PRD): BTC mRNA
Genes: BTC
Study NCT02326285 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02326285 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02386020 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT03320031 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT00591682 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study NCT01182688 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT00577837 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04684407 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04111913 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study NCT04111913 — Predictive Biomarker (PRD): FLT4 mRNA
Genes: FLT4; VEGFR3
Study NCT03679117 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03636204 — Predictive Biomarker (PRD): GRN mRNA
Genes: GRN
Study NCT00948753 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study NCT00007384 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT02860611 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02860611 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT02860611 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT00976820 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT03166891 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study NCT03166891 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03327909 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00494234 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT00494234 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT02773381 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT00030056 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02047864 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00005167 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00983307 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00983307 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04601935 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT04560491 — Predictive Biomarker (PRD): SLN mRNA
Genes: SLN
Study NCT01192997 — Surrogate Endpoint (SUR): Serum bactericidal antibody
Study NCT04051398 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT01428258 — Surrogate Endpoint (SUR): Plasma phenylalanine
Study NCT03868423 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT03868423 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT01174407 — Predictive Biomarker (PRD): CD55 mRNA
Genes: CD55; CR; DAF
Study NCT02463916 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02311764 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT02590796 — Predictive Biomarker (PRD); Safety Biomarker (SAF): MHC class I polypeptide-related sequence A
Genes: MICA; PERB11.1
Study NCT02904798 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT05638932 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT03157804 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT03157804 — Predictive Biomarker (PRD): FANCA mRNA
Genes: FANCA; FAA; FACA; FANCH
Study NCT03829462 — Predictive Biomarker (PRD): CCND1
Genes: U21B31
Study NCT02257502 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02257502 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT04555382 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT01489319 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT02957526 — Predictive Biomarker (PRD): Hormone receptor
Study NCT00482573 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02322281 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02343042 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT02686047 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT00898183 — Predictive Biomarker (PRD): TBXT mRNA
Genes: TBXT; T
Study NCT02785848 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT04210869 — Predictive Biomarker (PRD): ASL mRNA
Genes: ASL
Study NCT01216956 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT01216956 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01216956 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT01045408 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study NCT03358017 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT03358017 — Predictive Biomarker (PRD): WWTR1 mRNA
Genes: WWTR1; TAZ
Study NCT03792373 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03792373 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT03792373 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT03282461 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03282461 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00537602 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT00537602 — Pharmacodynamic Biomarker (PDY): Nasal potential difference
Study NCT02926872 — Predictive Biomarker (PRD): LIPA mRNA
Genes: LIPA
Study NCT00845351 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT02595983 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT00517764 — Safety Biomarker (SAF): BDNF
Study NCT05020132 — Predictive Biomarker (PRD): LARS1 mRNA
Genes: LARS1; KIAA1352; LARS
Study NCT04268290 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study NCT02724332 — Predictive Biomarker (PRD): ASPH mRNA
Genes: ASPH; BAH
Study NCT04329507 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04646954 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT02694744 — Surrogate Endpoint (SUR): Serum potassium
Study NCT02764957 — Predictive Biomarker (PRD): CGA mRNA
Genes: CGA
Study NCT02764957 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04304573 — Surrogate Endpoint (SUR): Serum calcium
Study NCT04304573 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT02160080 — Predictive Biomarker (PRD): BOC mRNA
Genes: BOC; UNQ604/PRO1190
Study NCT02671084 — Predictive Biomarker (PRD): MB mRNA
Genes: MB